Logo
Logo
  • Stories
  • Voices
  • Podcasts
  • WSJ
  • Search
  • Log In
  • Subscribe
  • Stories
  • Voices
  • Podcasts
  • WSJ

Follow Us

Full coverage: Health

Private practice? How Revenue tackled professionals transferring their business to a company

Many medical and other professionals have transferred their trade to a company. Now a doctor has been found personally liable for tax on fees earned through the new structure.

Eoin O'Shea
1st Feb, 2022 - 7 min read

Investors to weigh up HealthBeacon’s ten-fold growth predictions as it raises €25m

HealthBeacon helps patients self-administer medications. Now investors must weigh-up its tenfold growth predications, as it seeks to raise €25 million from a stock market flotation.

Tom Lyons
26th Nov, 2021 - 2 min read

Global investors hand Nuritas $45m to build out its peptide discovery platform

As an early-stage biotechnology company, Nuritas lives and dies by its investors' backing. A big new funding round that includes big names from the US, Europe and the UK is a vote of confidence in the company's prospects.

Ian Kehoe
11th Nov, 2021 - 2 min read

Nuritas is one of Ireland’s most vaunted start-ups. So why are its auditors so concerned?

Nuritas operates at the cutting edge of biotechnology and has a blue-chip roster of shareholders and backers. But its losses are mounting and its auditors are referencing “material uncertainty”. Just what is going on?

Ian Kehoe
29th Oct, 2021 - 4 min read

All vets great and small: the big business battle for veterinary ownership

Corporate veterinary groups have been “‘buying like blazes” in Ireland since a recent rule change, despite political pressure to keep them out. What does it mean for the business of being a vet?

Hannah Quinn-Mulligan
28th Oct, 2021 - 9 min read

Doctors, dentists and the gig economy: Inside Revenue’s assault on tax status of medical professionals

A clinic owner claimed doctors and dental practitioners were contractors. Revenue recast them as employees. The subsequent dispute has far-reaching implications for medical and other professionals.

Thomas Hubert
5th Oct, 2021 - 7 min read

Meat factories and dealing with the bull

Hannah Quinn-Mulligan reflects on the frustrations and inconsistencies presented by the authorities following her year-long investigation into Covid-19 outbreaks in meat factories.

Hannah Quinn-Mulligan
13th Sep, 2021 - 5 min read

Meat factories and Covid-19 – Part 2: Pay, conditions and bogus subcontracting via Poland

The second part of our investigation into the spread of the pandemic among meat factory staff examines why some of them fell through the safety net established to keep workers away from each other when they posed a risk of infection.

Hannah Quinn-Mulligan
8th Sep, 2021 - 6 min read

Special investigation: Meat factories and Covid-19 – the unsacrificed lamb

As cases of Covid-19 in meat factories grow higher than last year, the first instalment of a two-part, year-long investigation unveils how the meat industry got carte blanche to remain open when other industries were forced to shut down.

Hannah Quinn-Mulligan
7th Sep, 2021 - 17 min read

A Vatful of drugs: The tax implications of an €8m pharma rebate row

After The Currency exposed the volume deals struck by a medicine manufacturer with private hospitals and health insurers, our tax expert explores the ramification of the Vat dispute they triggered.

Eoin O'Shea
6th Aug, 2021 - 6 min read
« Previous 1 2 3 4 5 6 7 Next »
Logo
  • Advertise
  • About
  • Contact
  • Terms and Conditions
  • Privacy

© 2026 Currency Media Limited

Sign In

Forgot your password?
Logo

Not a subscriber yet?

Create an account